Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scar Heal is a Florida-based skin-health and scar-management company that markets silicone-based scar care products and related skincare products under the Rejuvaskin brand. The company appears to operate primarily as a commercial-stage medical skincare business rather than a drug-development biotech, with products focused on prevention and management of surgical, traumatic, burn, keloid, and hypertrophic scars. Its core portfolio includes silicone sheeting and silicone gel products such as Scar Fx and RejuvaSil, along with scar creams and broader skin-health products. Scar Heal also markets physician-recommended scar-management kits and emphasizes science-backed, non-invasive scar care sold internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scar Heal.